Filters

Prescrire international

Showing results (101-110 of 1,424) with videos related to

Pageof 143
Sort By:
Prescrire International|November 7, 2000
Pneumococcal vaccination for elderly subjects: license extension. Still no proof of clinical efficacy
Prescrire International|November 7, 2000
Indications and choice of antihypertensive drugs (cont'd): British recommendations
Prescrire International|February 5, 2019
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms
Prescrire International|January 16, 2019
ruxolitinib (JAKAVI°) and polycythaemia vera Inconclusive evaluation
Prescrire International|January 16, 2019
bevacizumab (Avastin°) in persistent, recurrent or metastatic cervical cancer: Prolongs survival by a few months, but highly toxic
Prescrire International|January 16, 2019
intravenous cangrelor (Kengrexal°) and coronary angioplasty: No advantage over first-line clopidogrel
Prescrire International|January 16, 2019
dulaglutide (Trulicity°) weekly in type 2 diabetes: Cardiovascular reactions should be better documented
Prescrire International|January 16, 2019
Ezetimibe + statin: insufficient benefit
Prescrire International|February 8, 2019
Osteoarthritis of the knee
Prescrire International|February 8, 2019
Hypertension Targeting 120 mmHg: survival benefit after 3 years, but high renal risk
Pageof 143

Showing results (101-110 of 1,424) with videos related to

Sort By:
Pageof 143
Prescrire International|November 7, 2000
Pneumococcal vaccination for elderly subjects: license extension. Still no proof of clinical efficacy
Prescrire International|November 7, 2000
Indications and choice of antihypertensive drugs (cont'd): British recommendations
Prescrire International|February 5, 2019
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms
Prescrire International|January 16, 2019
ruxolitinib (JAKAVI°) and polycythaemia vera Inconclusive evaluation
Prescrire International|January 16, 2019
bevacizumab (Avastin°) in persistent, recurrent or metastatic cervical cancer: Prolongs survival by a few months, but highly toxic
Prescrire International|January 16, 2019
intravenous cangrelor (Kengrexal°) and coronary angioplasty: No advantage over first-line clopidogrel
Prescrire International|January 16, 2019
dulaglutide (Trulicity°) weekly in type 2 diabetes: Cardiovascular reactions should be better documented
Prescrire International|January 16, 2019
Ezetimibe + statin: insufficient benefit
Prescrire International|February 8, 2019
Osteoarthritis of the knee
Prescrire International|February 8, 2019
Hypertension Targeting 120 mmHg: survival benefit after 3 years, but high renal risk
Pageof 143
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us